320-x-100_uti_gold.jpg" alt="Advertisement">
09-06-2021 02:00 PM | Source: Reuters
India's Hetero wins emergency use nod to make Roche's COVID-19 drug
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
BENGALURU - Indian drug developer Hetero said on Monday that it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's COVID-19 drug.
(Reporting by Shivani Singh in Bengaluru; Editing by Devika Syamnath)
Latest News
Nail Fashion Trends: The Art of Expressing Style Thr...
Sustainable Living: Tips for a Greener Lifestyle
PM Narendra Modi to attend Christmas celebrations ho...
Government launching 3 apps to protect consumers in ...
Kia to launch compact SUV `Syros` in India next year
GST recommendations to create business-friendly envi...
CII seeks priority sector lending for new and emergi...
The Wealth of Experiences: How Travel and Cultural E...
India`s tax panel rejects airlines` call to add avia...
Rozgar Mela: PM Narendra Modi to distribute 71,000 a...
